CorMatrix Receives Carotid Artery Repair Indication for its CorMatrixECM

CorMatrix Cardiovascular, Inc., a medical device company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body’s innate ability to repair damaged cardio-vascular tissue, announced today that they have received CE Mark clearance to market its CorMatrix® ECM® for Carotid Repair, which utilises the company’s proprietary ECM Technology.